When combined with diet and physical activity changes, brand-name Wegovy is approved by the Food and Drug Administration (FDA) for the following purposes: Weight loss in patients 12 years or older with obesity Body weight reduction in adults who are overweight and have at least one weight-related condition, such as high blood pressure, obstructive sleep apnea (OSA), or Type 2 diabetes Cardiovascular risk reduction in adults with heart disease and either obesity or overweight Treatment of noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH) in adults with moderate to advanced liver fibrosis Wegovy is a glucagon-like peptide-1 receptor agonist (GLP-1 receptor agonist)
Breast Cancer Res Treat (2012) 132(2):44961
, & Mao, J
84% noted improved energy, and better sleep in Lumitys clinical trial.* HEALTHY SKIN, HAIR & NAILS - In a placebo controlled, double-blind clinical study conducted on 50 women, ages 35-65 for 12 weeks, Lumity showed statistically significant improvement in skin roughness, dullness, hydration and firmness
Research-grade senolytic dosage Ideal For Those seeking cutting-edge cellular senescence intervention, longevity optimization, and age-related cellular health support
Our experts are ready to provide comprehensive assistance and guidance tailored to your skincare needs
